In the Randomized Evaluation of Long-Term Anticoagulant Therapy ( RELY ) trial , dabigatran , with @ % renal elimination , displayed superiority over warfarin for prevention of stroke and systemic embolism in the @-mg dose and significantly less major bleeding in the @-mg dose in @ @ patients with nonvalvular atrial fibrillation .